Posts tagged “LabCorp”
Red Hat-SAP mobile deal; Microsoft CEO earns $84M; LabCorp's new HIV test; NC falls to 3rd in biz climate; Honda Aircraft expands
In today's Bulldog wrapup of life science and technology news: Red Hat and SAP partner in the cloud; Microsoft's CEO earns $84 million pay package; LabCorp launches new HIV test; North Carolina slips in a business climate survey; and Honda Aircraft keeps growing in the Triad.
LabCorp-LipoScience deal advances; Red Hat's new women awards; a comet landing; eBay's miss; NetFlix plunge
In today's wrapup of tech and life science news: LabCorp's $85M acquisition of LipoScience clears a key hurdle; Red Hat announces women in Open Source awards; a comet landing is at hand; eBay's miss; and NetFlix stock plunges.
BD reboots startup program; NePhroGenex clinical trial; Red Hat Summit; OxyBio update; LabCorp board shuffle
In the latest Bulldog roundup of life science and technology news: BD Technologies re-launches incubator program; NePhroGenex reports a loss for 2013 but secures providers for big clinical trial; Red Hat adds IBM exec to Summit lineup; OxyBio can resume testing; and LabCorp shuffles board.
Google Glass goes for style; Box plans IPO; nCino, LabCorp name new execs; Disney makes YouTube play
The latest Bulldog roundup: Google Glass goes for fashion in deal with Ray-Ban, Oakley; web storage startup Box is going public; cloud banking firm nCino adds a VP for revenue and strategy; LabCorp hires a new CFO; and Disney is buying Maker Studios for $500 million.
LabCorp (NYSE:LH) processed more tests in the fourth quarter than it did same period in the prior year but it made less money per test and the laboratory testing and diagnostics firm's revenue and earnings results fell short of analyst estimates.
LabCorp is among the first laboratories offering NanoString Technologies' prognostic breast cancer test, which has been shown in studies to offer better information compared to existing cancer assays.
Myriad Genetics, the company that went all the way to the U.S. Supreme Court seeking patents on human genes, now claims LabCorp's new genetic tests for breast cancer infringe on its patents. Read more about the suit.
Garheng Kong, a former partner at venture capital firm Intersouth Partners in Durham, is the newest member of the board at lab testing giant LabCorp.